ATC Group: G01AF19 Sertaconazole

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of G01AF19 in the ATC hierarchy

Level Code Title
1 G Genito urinary system and sex hormones
2 G01 Gynecological antiinfectives and antiseptics
3 G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
4 G01AF Imidazole derivatives
5 G01AF19

Active ingredients in G01AF19

Active Ingredient Description
Sertaconazole

Sertaconazole, an azole antifungal agent, inhibits fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylase enzyme. This enzyme functions to convert lanosterol to ergosterol. Ergosterol is a key component of fungal cell membranes and lack of this component leads to fungal cell injury by leakage of key constituents in the cytoplasm from the cell.

Medicines in this ATC group

Ecuador (EC)

Estonia (EE)

Germany (DE)

Hong Kong (HK)

Spain (ES)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.